2,450 HIV-Positive People In One Nigerian State Register For No-Cost Treatment, Official Says
Main Category: HIV / AIDSArticle Date: 15 Jan 2009 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
About 2,450 HIV-positive people in the Nigerian state of Niger have registered for no-cost treatment that its HIV/AIDS agency provides, Baba Umaru, director-general of the agency, said last week, Nigeria's Daily Trust reports. He added that at least 140 HIV-positive children are receiving HIV treatment. In addition, the agency has counseled 77,000 people in the state and identified 6,000 HIV cases, Umaru said.
According to Umaru, government officials in Niger recently launched an HIV awareness campaign because they were concerned about the low number of people seeking HIV treatment. Umaru said that Niger's State Assembly granted "full autonomy" to the HIV/AIDS agency to implement the campaign and promote HIV testing and treatment options. "More people are approaching the agency to know their status," Umaru said, adding that "it is a daily affair for us to receive requests" for HIV counseling or testing. He said he was confident that Niger's HIV/AIDS prevalence would decline as a result of the government's actions to address the disease, adding that additional assistance from international donor organizations would enable the agency to provide services to more HIV-positive people (Daily Trust, 1/10).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/135531.php>
APA
http://www.medicalnewstoday.com/releases/135531.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



